Search results for "osteoporosis."

showing 10 items of 380 documents

Osteoporosis post-menopáusica, una revisión exhaustiva de su manejo actual

2016

La Osteoporosis es una enfermedad caracterizada por una baja densidad mineral y un deterioro de la micro-arquitectura ósea, lo que desencadena una fragilidad de la misma y una mayor probabilidad de tener una fractura. Se estima que unos 200 millones de personas la sufren actualmente, y que el 30-40% de las mujeres post-menopáusicas la padecen. Además, debido a que es una enfermedad en muchas ocasiones silente, un gran porcentaje de mujeres no están diagnosticadas. El presente trabajo tiene como objetivo realizar una revisión sistemática y exhaustiva de la bibliografía publicada a nivel mundial sobre el diagnóstico y tratamiento de la osteoporosis post-menopaúsica, incluyendo medidas paliati…

UNESCO::CIENCIAS MÉDICASosteoporosis post-menopáusica:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review

2015

Vitamin D deficiency further increases the risk of osteoporosis in HIV-positive patients coinfected with hepatitis C virus (HCV); however, it is still unclear whether HCV-related increased fracture risk is a function of the severity of liver disease. The aim of this review was to identify studies on associative vitamin D deficiency patterns in high-risk populations such as HIV/HCV coinfected patients. We did this by searching MEDLINE and EMBASE databases, from inception to August 2014, and included bibliographies. The final 12 articles selected are homogeneous in terms of age but heterogeneous in terms of sample size, participant recruitment, and data source. Most of the HIV/HCV coinfected …

VitaminPathologymedicine.medical_specialtySettore MED/17 - Malattie InfettiveEndocrinology Diabetes and MetabolismHepatitis C virusOsteoporosisMEDLINEReview ArticleHIV/HCV coinfected patientS VITAMIN Dmedicine.disease_causelcsh:Diseases of the endocrine glands. Clinical endocrinologyvitamin D deficiencyLiver diseasechemistry.chemical_compoundEndocrinologyInternal medicinemedicineVitamin D and neurologylcsh:RC648-665Vitamin d supplementationEndocrine and Autonomic Systemsbusiness.industryvirus diseasesmedicine.diseasechemistrybusiness
researchProduct

Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment

2021

Studies on vitamin/hormone D deficiency have received a vast amount of attention in recent years, particularly concerning recommendations, guidelines, and treatments. Moreover, vitamin D’s role as a hormone has been confirmed in various enzymatic, metabolic, physiological, and pathophysiological processes related to many organs and systems in the human body. This growing interest is mostly due to the evidence that modest-to-severe vitamin D deficiency is widely prevalent around the world. There is broad agreement that optimal vitamin D status is necessary for bones, muscles, and one’s general health, as well as for the efficacy of antiresorptive and anabolic bone-forming treatments. Food su…

VitamincholecalciferolcalcitriolSettore MED/09 - Medicina InternaCalcitriolEndocrinology Diabetes and MetabolismcalcifediolOsteoporosisPhysiology030209 endocrinology & metabolismvitamin DReviewBiochemistryboneMicrobiologyvitamin D deficiency03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineVitamin D and neurology030212 general & internal medicineMolecular Biologybusiness.industryOsteoporosimedicine.diseaseosteoporosisQR1-502chemistryfractureCalcifediolVitamin D.CholecalciferolbusinessHormonemedicine.drugMetabolites
researchProduct

Effect of exercises with weight vests and a patient education programme for women with osteopenia and a healed wrist fracture: a randomized, controll…

2015

Background Exercise programmes have shown to be important for the prevention of fractures in patients with established osteoporosis. However, few studies have evaluated the effect of such programmes for women with low bone mineral density (BMD) (osteoporosis or osteopenia) who have already suffered a fracture. Studies have indicated that exercise programmes concentrating on muscular strength and dynamic balance have a positive effect on significant risk factors for falls such as quadriceps strength and balance. The aim of the present study was to assess the effect of a 6-month exercise programme and a patient education component (OsteoACTIVE) on quadriceps strength, BMD, dynamic balance, wa…

Wrist Jointmedicine.medical_specialtySports medicinemedicine.medical_treatmentOsteoporosisPhysical strengthlaw.inventionQuadriceps strengthPhysical medicine and rehabilitationRheumatologyQuality of lifeRandomized controlled trialPatient Education as TopiclawmedicineHumansOrthopedics and Sports MedicineSingle-Blind MethodMuscle StrengthExerciseAgedAged 80 and overRehabilitationbusiness.industryOsteopeniaRehabilitationWeight vestResistance TrainingMiddle Agedmedicine.diseasePhysical activity levelExercise TherapyOsteopeniaBone Diseases MetabolicTreatment OutcomePhysical therapyFemalebusinessRadius FracturesResearch ArticleFollow-Up StudiesBMC Musculoskeletal Disorders
researchProduct

studio osservazionale retrospettivo della correlazione tra riduzione della massa ossea e disturbi comportamentali

Nel nostro studio sono stati esaminati due gruppi di soggetti, così suddivisi, un gruppo già con diagnosi strumentale di riduzione della massa ossea ed un gruppo controllo. Nel reclutamento del gruppo di controllo sono stati esclusi soggetti di età superiore a 65 anni, in terapia cortisonica per patologie croniche da più di sei mesi, individui che evidenziano all’anamnesi fattori che aumentano il rischio o le conseguenze delle cadute, quali disabilità, fattori ambientali, consumo di benzodiazepine, abuso di alcol o droghe, o con patologie note che possano essere responsabili di osteoporosi secondaria. La scheda di valutazione anamnestica, nei pazienti affetti da osteoporosi o osteopenia è c…

behavioral disorderfractureanorexiaSettore MED/33 - Malattie Apparato Locomotoreosteoporosiosteoporosis;fracture;anorexia; behavioral disorders;
researchProduct

Correlation between osteoporosis and cardiovascular disease

2014

Several evidences have shown in the last years a possible correlation between cardiovascular diseases and osteoporosis. Patients affected with osteoporosis, for example, have a higher risk of cardiovascular diseases than subjects with normal bone mass. However, the heterogeneous approaches and the different populations that have been studied so far have limited the strength of the findings. Studies conducted in animal models show that vascular calcification is a very complex mechanism that involves similar pathways described in the normal bone calcification. Proteins like BMP, osteopontin, osteoprotegerin play an important role at the bone level but are also highly expressed in the calcifie…

biologybusiness.industryMechanism (biology)OsteoporosisInflammationDiseaseMini-ReviewBioinformaticsmedicine.diseasemedicine.disease_causeOsteoprotegerinbiology.proteinMedicineOsteopontinmedicine.symptombusinessOxidative stressCalcificationClinical Cases in Mineral and Bone Metabolism
researchProduct

El prolapso genital como factor de riesgo de fractura osteoporótica en la mujer

2022

El estudio consiste en analizar la correlación existente entre el prolapso genital y la fractura osteoporótica, ambas patología de alta prevalencia en la mujer envejecida. Ya existen indicios biblliográficos (en estudios de datos poblacionales) de esta posible asociación, pero siempre de manera retrospectiva y nunca buscando esta asociación como objetivo principal, con los sesgos inherentes a cada perfil de estudio. Proponemos un estudio analítico, observacional y prospectivo con el fin de demostrar nuestra hipótesis principal; que el propaso de órganos pélvicos es un factor de riesgo independiente para fractura osteoporótica. Como objetivo secundario, intentaremos demostrar que existen mar…

biomarcadores de imagenUNESCO::CIENCIAS MÉDICAS ::Ciencias clínicas::GinecologíaUNESCO::CIENCIAS MÉDICASprolapso órganos pelvicos:CIENCIAS MÉDICAS ::Ciencias clínicas::Ginecología [UNESCO]:CIENCIAS MÉDICAS [UNESCO]:CIENCIAS MÉDICAS ::Medicina preventiva [UNESCO]osteoporosisUNESCO::CIENCIAS MÉDICAS ::Medicina preventivafractura osteoporótica
researchProduct

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020

2020

The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of patients, but also on the decision-making process by the majority of dentists and oral surgeons involved in MRONJ prevention (primary and secondary). The present paper reports the update of the conclusions from the Consensus Conference—held at the Symposium of the Italian Society of Oral Pathology and Medicine (SIPMO) (20 October 2018, Ancona, Italy)—after the newest recommendations (2020) on MRONJ were published by two scientific societies (Italian Societies of Maxillofacial Surgery and Oral Pathology and Medicine, SI…

bisphosphonateOral SurgeonHealth Toxicology and Mutagenesislcsh:MedicineMRONJantiangiogenic agents; antiresorptive drugs; bisphosphonates; cancer; denosumab; dentistry; MRONJ; oral surgery; osteoporosis; prevention models; bisphosphonate-associated osteonecrosis of the jaw; bone density conservation agents; diphosphonates; humans; Italy; quality of life0302 clinical medicineprevention modelCancerantiangiogenic agentsdentistryBone Density Conservation AgentsDiphosphonatesConference ReportBisphosphonatesAntiresorptive DrugsDenosumabItaly030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawDenosumabmedicine.drugoral surgerymedicine.medical_specialtyOral surgery03 medical and health sciencesOral surgeryAntiangiogenic agentsOral and maxillofacial pathologymedicinecancerHumansantiangiogenic agentantiresorptive drugsIntensive care medicinePrevention modelsbisphosphonatesantiresorptive drugAntiangiogenic agentsbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthdenosumab030206 dentistrymedicine.diseaseosteoporosisAntiresorptive drugsDentistryOsteoporosisprevention modelsbusinessAntiangiogenic agents; Antiresorptive drugs; Bisphosphonates; Cancer; Denosumab; Dentistry; MRONJ; Oral surgery; Osteoporosis; Prevention models
researchProduct

Bone Density, Balance and Quality of Life of Postmenopausal Women Taking Alendronate Participating in Different Physical Activity Programs

2010

Made available in DSpace on 2022-04-28T19:04:59Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-01-01 Background: The objective of this study was to determine the effects of different physical activity (PA) programs on bone density, balance and quality of life of postmenopausal women taking concomitant alendronate. A quasi-experimental study was conducted with 35 volunteers divided into four groups: practitioners of resistance training (RTG, n = 9, 49.8±4.2 years), judo (JUG, n = 11, 52.2±5.3 years), water aerobics (WAG, n = 8, 57.1±7.4 years) and the control group (CG, n = 7, 53.8±4.4 years). Methods: The following assessment tools were used: bone mineral density (BMD) measured by d…

bisphosphonatemedicine.medical_specialtyBone densitymedicine.medical_treatmentOsteoporosisUrologymenopauseRheumatologymedicineOrthopedics and Sports MedicineFemurpostural balanceOriginal ResearchBone mineralexercisebusiness.industrybone densityBisphosphonatemedicine.diseaseMenopausequality of lifeConcomitantPhysical therapyAnalysis of variancebusinesshuman activities
researchProduct

Anti-resorptive treatment in osteoporosis and their deleterious effects on maxillary bone metabolism in clinical dentistry

2017

Bisphosphonates (BPs) and other antiresorptive agents such as denosumab are widely prescribed for the treatment of osteoporosis and are also used in patients with multiple myeloma and metastatic breast or prostate cancer for avoiding bone reabsorption and fractures that result in increased morbidity–mortality among such individuals. Osteonecrosis of the jaws is an important complication of exposure to BPs or other antiresorptive agents, and although its prevalence is low, it can pose management problems. The definition, diagnosis, and classification of osteonecrosis have evolved since Marx reported the first cases in 2003. The present chapter offers a review and update on the existing diagn…

business.industrymedicine.medical_treatmentOsteoporosisDentistryBisphosphonatemedicine.diseaseBone resorptionBone remodelingProstate cancerDenosumabmedicinebusinessComplicationMultiple myelomamedicine.drug
researchProduct